| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4207880 | Clinics in Chest Medicine | 2007 | 17 Pages |
Abstract
This review assesses the available evidence supporting the use of drug combinations for the management of the various forms of pulmonary arterial hypertension (PAH). Ongoing and forthcoming randomized trials evaluating this strategy are also highlighted. Furthermore, new types of agents to treat PAH in the future are explored.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Dermot O'Callaghan, Sean P. Gaine,